2022 Hyundai Palisade SEL
3.8 L • 6 • 291 hp • FWD • AT
KM8R44HEXNU475119
Sales history: 1
Highlights
Condition
Not provided
Seller
Insurance • Farmers Insurance
Key included
Yes
Docs
Good
History
1 record
Drive
3.8 L • 6 • 291 hp • FWD • AT
Odometer
29,656 mi ≈ 47,727 km
Primary damage
All over
Docs
Salvage
Extra
Auction
VIN
KM8R44HEXNU475119
Lot number
58739174
Copart
Sale status
Sold
Seller type
Insurance
Seller
Farmers Insurance
Location
Nashville, TN
Description
Fuel type
Gasoline
Body color
Black
Body type
SUV
Generation
LX2
Trim
SEL
All sales final. Always run reports before bid
Sharing our own experience
Over the years, we’ve learned all the ins and outs of car importing — so you don’t have to.
How it works
A full step-by-step guide that walks you through the entire process — from signing up to receiving your car at your doorstep. Clear & beginner-friendly.
Purchase process
Knowledge base
A structured library of content covering every major topic in car importing — including terms, rules, key concepts, and important real-world nuances.
Import encyclopedia
Watch & learn
Short, practical videos packed with tips from real experience. No fluff, no theory — just what actually helps when importing a car from the US to Poland.
Watch guides
Popular Hyundai models
2022 Hyundai Palisade SEL • 3.8 L • 6 cyl • 291 hp • FWD • Automatic • Copart Lot: 58739174 • VIN: KM8R44HEXNU475119
Find out more about this 2022 Hyundai Palisade SEL, available at the Copart salvage car auction as lot #58739174 in Nashville, TN. This car has All over main damage. It is listed with start condition code. Odometer shows 29,656 mi. This Black Hyundai Palisade SUV is equipped with Gasoline 3.8 L engine, FWD drivetrain, Automatic transmission. Check the vehicle history report for KM8R44HEXNU475119 to access detailed information on accidents, ownership, and title status. Review pricing trends and uncover hidden issues before placing your bid.
We use cookies to improve your experience and analyze site usage, as outlined in our Privacy policy. By closing this message or continuing to browse, you consent to their use.
